Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Validation of a score tool for measurement of histological severity in juvenile dermatomyositis and association with clinical severity of disease.

Varsani H, Charman SC, Li CK, Marie SK, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith AM, Jacques TS, Lundberg IE, Minetti C, Nennesmo I, Rushing EJ, Sallum AM, Sewry C, Pilkington CA, Holton JL, Wedderburn LR; UK Juvenile Dermatomyositis Research Group.

Ann Rheum Dis. 2015 Jan;74(1):204-10. doi: 10.1136/annrheumdis-2013-203396. Epub 2013 Sep 24.

2.

International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: a tool for potential use in clinical trials.

Wedderburn LR, Varsani H, Li CK, Newton KR, Amato AA, Banwell B, Bove KE, Corse AM, Emslie-Smith A, Harding B, Hoogendijk J, Lundberg IE, Marie S, Minetti C, Nennesmo I, Rushing EJ, Sewry C, Charman SC, Pilkington CA, Holton JL; UK Juvenile Dermatomyositis Research Group.

Arthritis Rheum. 2007 Oct 15;57(7):1192-201.

3.

Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis.

Nistala K, Varsani H, Wittkowski H, Vogl T, Krol P, Shah V, Mamchaoui K, Brogan PA, Roth J, Wedderburn LR.

Arthritis Res Ther. 2013 Sep 23;15(5):R131. doi: 10.1186/ar4311.

4.

Whole-body MRI in the assessment of disease activity in juvenile dermatomyositis.

Malattia C, Damasio MB, Madeo A, Pistorio A, Providenti A, Pederzoli S, Viola S, Buoncompagni A, Mattiuz C, Beltramo A, Consolaro A, Ravelli A, Ruperto N, Picco P, Magnano GM, Martini A.

Ann Rheum Dis. 2014 Jun;73(6):1083-90. doi: 10.1136/annrheumdis-2012-202915. Epub 2013 May 1.

PMID:
23636654
5.

MHC class I and II expression in juvenile dermatomyositis skeletal muscle.

Sallum AM, Kiss MH, Silva CA, Wakamatsu A, Sachetti S, Lotufo S, Matsumura N, Marie SK.

Clin Exp Rheumatol. 2009 May-Jun;27(3):519-26.

PMID:
19604449
6.

Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system.

Davis WR, Halls JE, Offiah AC, Pilkington C, Owens CM, Rosendahl K.

Rheumatology (Oxford). 2011 Dec;50(12):2237-44. doi: 10.1093/rheumatology/ker262. Epub 2011 Oct 4.

7.

Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis.

Dorph C, Englund P, Nennesmo I, Lundberg IE.

Ann Rheum Dis. 2006 Dec;65(12):1565-71. Epub 2006 Jul 10.

8.

Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.

McCann LJ, Garay SM, Ryan MM, Harris R, Riley P, Pilkington CA.

Rheumatology (Oxford). 2007 Aug;46(8):1363-6. Epub 2007 Jun 14.

9.

What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis?

Wargula JC, Lovell DJ, Passo MH, Bove KE, Santangelo JD, Levinson JE.

Clin Exp Rheumatol. 2006 May-Jun;24(3):333-43.

PMID:
16870106
10.

Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis.

Gitiaux C, De Antonio M, Aouizerate J, Gherardi RK, Guilbert T, Barnerias C, Bodemer C, Brochard-Payet K, Quartier P, Musset L, Chazaud B, Desguerre I, Bader-Meunier B.

Rheumatology (Oxford). 2016 Mar;55(3):470-9. doi: 10.1093/rheumatology/kev359. Epub 2015 Sep 30.

11.

Morphometric analyses of normal pediatric brachial biceps and quadriceps muscle tissue.

Sallum AM, Varsani H, Holton JL, Marie SK, Wedderburn LR.

Histol Histopathol. 2013 Apr;28(4):525-30. Epub 2013 Feb 8.

12.

Whole-body MRI: a helpful diagnostic tool for juvenile dermatomyositis case report and review of the literature.

Tzaribachev N, Well C, Schedel J, Horger M.

Rheumatol Int. 2009 Oct;29(12):1511-4. doi: 10.1007/s00296-009-0890-y. Epub 2009 Mar 20. Review.

PMID:
19301008
13.

Expression of HLA class I antigens in skeletal muscle is a diagnostic marker in juvenile dermatomyositis.

Topaloglu H, Muntoni F, Dubowitz V, Sewry C.

J Child Neurol. 1997 Jan;12(1):60-3.

PMID:
9010797
14.
15.

Immunohistological analysis of CD59 and membrane attack complex of complement in muscle in juvenile dermatomyositis.

Gonçalves FG, Chimelli L, Sallum AM, Marie SK, Kiss MH, Ferriani VP.

J Rheumatol. 2002 Jun;29(6):1301-7.

PMID:
12064850
16.

Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.

Maillard SM, Jones R, Owens C, Pilkington C, Woo P, Wedderburn LR, Murray KJ.

Rheumatology (Oxford). 2004 May;43(5):603-8. Epub 2004 Feb 24.

17.

Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence.

Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM.

Arthritis Rheum. 2003 Feb 15;49(1):7-15.

18.

Whole-body magnetic resonance imaging in the assessment of muscular involvement in juvenile dermatomyositis/polymyositis patients.

Castro TC, Lederman H, Terreri MT, Caldana WI, Zanoteli E, Hilário MO.

Scand J Rheumatol. 2014;43(4):329-33. doi: 10.3109/03009742.2013.868509. Epub 2014 Feb 7.

PMID:
25087579
19.

Immunohistochemical analysis of adhesion molecule expression on muscle biopsy specimens from patients with juvenile dermatomyositis.

Sallum AM, Marie SK, Wakamatsu A, Sachetti S, Vianna MA, Silva CA, Kiss MH.

J Rheumatol. 2004 Apr;31(4):801-7.

PMID:
15088312
20.

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis.

Ruperto N, Ravelli A, Murray KJ, Lovell DJ, Andersson-Gare B, Feldman BM, Garay S, Kuis W, Machado C, Pachman L, Prieur AM, Rider LG, Silverman E, Tsitsami E, Woo P, Giannini EH, Martini A; Paediatric Rheumatology International Trials Organization (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRCSG).

Rheumatology (Oxford). 2003 Dec;42(12):1452-9. Epub 2003 Jun 27. Review.

Items per page

Supplemental Content

Write to the Help Desk